Skip to main content
Home
  • Home
  • Avemar Publications
  • Journals
  • Research centers
  • Avemar in cancer treatment
HU US-UK FR ES DE 中文
Voigt W, Mueller T, Jordan K, Reipisch F, Nerger K, Schmoll HJ (2009): Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines . European Journal of Cancer Supplements.
Telekes A, Tejeda M, Gaál D, Szűcs I (2007): Avemar Inhibits the Growth of Mouse and Human Xenograft Mammary Carcinomas Comparable To Endocrine Treatments. Journal of Clinical Oncology.
Szende B, Tompa A, Kocsis Z, marcsek Z, Jakab M (2004): The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment. Cancer Biotherapy & Radiopharmaceuticals.
Szende B, Hidvégi M, Tompa A, Kocsis Z, marcsek Z, Jakab M (2003): Chemoprevention with tamoxifen and Avemar by inducing apoptosis on MCF-7 (ER+) breast cancer cells. 2nd Congress of the World Society for Breast Health.

Search form

  • Papers on Avemar
  • What is Avemar?
  • Avemar in cancer treatment
  • Scientific background
  • Mechanism of action
  • Safety profile

The information on this website is provided for informational purposes only and is not meant to diagnose or treat any health problem or disease or be a substitute for advice provided by a doctor or other qualified health care professional. Patients should always consult with a doctor or other health care professionals for medical advice or information about a diagnosis and/or treatment. In the case of diagnosis or treatment of any disease, particularly tumour related diseases, a health care professional should always be consulted. Do not attempt to self-treat.

Privacy policy

Avemar Design System by Gilanyi & Magos Professional Design.

Disclaimer


This site is intended for use by non-US citizens only.

If you are from the US, please visit this site.

If you are NOT from the US, please continue here.